A new approach on bullous pemphigoid therapy.
Saouli
Z
Z
Papadopoulos
A
A
Kaiafa
G
G
Girtovitis
F
F
Kontoninas
Z
Z
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001706:Biopsy; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D012867:Skin / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab